AxoGen (AXGN) Revenue & Revenue Breakdown
AxoGen Revenue Highlights
Latest Revenue (Y)
$159.01M
Latest Revenue (Q)
$47.91M
AxoGen Revenue by Period
AxoGen Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $159.01M | 14.74% |
| 2022-12-31 | $138.58M | 8.81% |
| 2021-12-31 | $127.36M | 13.41% |
| 2020-12-31 | $112.30M | 5.24% |
| 2019-12-31 | $106.71M | 27.13% |
| 2018-12-31 | $83.94M | 38.91% |
| 2017-12-31 | $60.43M | 47.00% |
| 2016-12-31 | $41.11M | 50.41% |
| 2015-12-31 | $27.33M | 62.52% |
| 2014-12-31 | $16.82M | 53.62% |
| 2013-12-31 | $10.95M | 42.33% |
| 2012-12-31 | $7.69M | 58.61% |
| 2011-12-31 | $4.85M | 5213.15% |
| 2010-12-31 | $91.27K | -99.63% |
| 2009-12-31 | $24.91M | 34160.81% |
| 2008-12-31 | $72.71K | -27.60% |
| 2007-12-31 | $100.43K | -20.71% |
| 2006-12-31 | $126.66K | -71.43% |
| 2005-12-31 | $443.35K | -58.37% |
| 2004-12-31 | $1.06M | -85.28% |
| 2003-12-31 | $7.24M | 5.62% |
| 2002-12-31 | $6.85M | -56.98% |
| 2001-06-30 | $15.93M | 9.13% |
| 2000-06-30 | $14.60M | 18.67% |
| 1999-06-30 | $12.30M | -4.65% |
| 1998-06-30 | $12.90M | 4.88% |
| 1997-06-30 | $12.30M | -6.11% |
| 1996-06-30 | $13.10M | -7.09% |
| 1995-06-30 | $14.10M | 31.78% |
| 1994-06-30 | $10.70M | 16.30% |
| 1993-06-30 | $9.20M | - |
AxoGen generated $159.01M in revenue during NA 2023, up 14.74% compared to the previous quarter, and up 189.44% compared to the same period a year ago.
AxoGen Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $47.91M | 15.79% |
| 2024-03-31 | $41.38M | -3.60% |
| 2023-12-31 | $42.92M | 4.00% |
| 2023-09-30 | $41.27M | 8.17% |
| 2023-06-30 | $38.16M | 4.07% |
| 2023-03-31 | $36.66M | 1.38% |
| 2022-12-31 | $36.16M | -2.15% |
| 2022-09-30 | $36.96M | 7.27% |
| 2022-06-30 | $34.45M | 11.12% |
| 2022-03-31 | $31.01M | -1.68% |
| 2021-12-31 | $31.54M | 1.07% |
| 2021-09-30 | $31.20M | -7.08% |
| 2021-06-30 | $33.58M | 8.19% |
| 2021-03-31 | $31.04M | -4.49% |
| 2020-12-31 | $32.49M | -2.79% |
| 2020-09-30 | $33.43M | 51.15% |
| 2020-06-30 | $22.12M | -8.84% |
| 2020-03-31 | $24.26M | -13.85% |
| 2019-12-31 | $28.16M | -1.41% |
| 2019-09-30 | $28.56M | 6.98% |
| 2019-06-30 | $26.70M | 14.67% |
| 2019-03-31 | $23.29M | -0.63% |
| 2018-12-31 | $23.43M | 3.41% |
| 2018-09-30 | $22.66M | 10.08% |
| 2018-06-30 | $20.58M | 19.26% |
| 2018-03-31 | $17.26M | 1.70% |
| 2017-12-31 | $16.97M | 5.76% |
| 2017-09-30 | $16.05M | 5.79% |
| 2017-06-30 | $15.17M | 23.91% |
| 2017-03-31 | $12.24M | 7.30% |
| 2016-12-31 | $11.41M | 1.82% |
| 2016-09-30 | $11.21M | 7.93% |
| 2016-06-30 | $10.38M | 27.99% |
| 2016-03-31 | $8.11M | 3.88% |
| 2015-12-31 | $7.81M | -4.23% |
| 2015-09-30 | $8.15M | 27.06% |
| 2015-06-30 | $6.42M | 29.61% |
| 2015-03-31 | $4.95M | 3.29% |
| 2014-12-31 | $4.79M | 2.62% |
| 2014-09-30 | $4.67M | 10.85% |
| 2014-06-30 | $4.21M | 34.28% |
| 2014-03-31 | $3.14M | 5.15% |
| 2013-12-31 | $2.98M | 0.92% |
| 2013-09-30 | $2.96M | 3.33% |
| 2013-06-30 | $2.86M | 33.57% |
| 2013-03-31 | $2.14M | 4.79% |
| 2012-12-31 | $2.04M | 3.23% |
| 2012-09-30 | $1.98M | -1.57% |
| 2012-06-30 | $2.01M | 21.72% |
| 2012-03-31 | $1.65M | 21.43% |
| 2011-12-31 | $1.36M | 19.36% |
| 2011-09-30 | $1.14M | -49.17% |
| 2011-06-30 | $2.24M | -38.09% |
| 2011-03-31 | $3.63M | 8506.99% |
| 2010-12-31 | $42.12K | 59.70% |
| 2010-09-30 | $26.37K | 710.48% |
| 2010-06-30 | $3.25K | -83.34% |
| 2010-03-31 | $19.53K | -99.92% |
| 2009-12-31 | $24.23M | 99981.53% |
| 2009-09-30 | $24.21K | -96.03% |
| 2009-06-30 | $610.31K | 1349.43% |
| 2009-03-31 | $42.11K | 29.22% |
| 2008-12-31 | $32.59K | 132.39% |
| 2008-09-30 | $14.02K | 176.30% |
| 2008-06-30 | $5.08K | -75.87% |
| 2008-03-31 | $21.03K | 100.00% |
| 2007-12-31 | - | - |
AxoGen generated $47.91M in revenue during Q2 2024, up 15.79% compared to the previous quarter, and up 130.68% compared to the same period a year ago.
AxoGen Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ITGR | Integer | $1.60B | $753.01M |
| CNMD | CONMED | $1.24B | $332.10M |
| LIVN | LivaNova | $1.15B | $318.60M |
| AORT | Artivion | $354.00M | $98.02M |
| FNA | Paragon 28 | $216.39M | $61.02M |
| ANIK | Anika Therapeutics | $166.66M | $41.92M |
| AXGN | AxoGen | $159.01M | $47.91M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SIBN | SI-BONE | $138.89M | $39.97M |
| SRDX | Surmodics | $132.58M | $30.34M |
| RXST | RxSight | $89.08M | $45.52M |
| LUNG | Pulmonx | $68.67M | $20.78M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
AXGN Revenue FAQ
What is AxoGen’s yearly revenue?
AxoGen's yearly revenue for 2023 was $159.01M, representing an increase of 14.74% compared to 2022. The company's yearly revenue for 2022 was $138.58M, representing an increase of 8.81% compared to 2021. AXGN's yearly revenue for 2021 was $127.36M, representing an increase of 13.41% compared to 2020.
What is AxoGen’s quarterly revenue?
AxoGen's quarterly revenue for Q2 2024 was $47.91M, a 15.79% increase from the previous quarter (Q1 2024), and a 25.57% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $41.38M, a -3.60% decrease from the previous quarter (Q4 2023), and a 12.86% increase year-over-year (Q1 2023). AXGN's quarterly revenue for Q4 2023 was $42.92M, a 4.00% increase from the previous quarter (Q3 2023), and a 18.69% increase year-over-year (Q4 2022).
What is AxoGen’s revenue growth rate?
AxoGen's revenue growth rate for the last 3 years (2021-2023) was 24.85%, and for the last 5 years (2019-2023) was 49.01%.